Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Secretin (human)
Drug ID BADD_D02000
Description Human secretin is a gastrointestinal peptide hormone that regulates secretions in the stomach, pancreas, and liver. The hormone is produced from the enterochromaffin cells in the duodenum in response to the duodenal content with the pH less than 4.5 [L1875]. The main action of secretin is to stimulate the pancreas to secrete pancreatic juice for pH regulation in the small intestines. Secretin is also responsible in body fluid homeostasis [A32276] and bile production. Although it is a gastrointestinal hormone, secretin is also considered as a neuropeptide hormone since it is also expressed in the central nervous system [A32275]. Purified synthetic human secretin, also referred to as RG1068, is available as an intravenous injection under the market name ChiRhoStim ® in the U.S.. It contains an amino acid sequence identical to the naturally occurring hormone consisting of 27 amino acids [FDA Label] that supports α-helical formation [A32275]. The carboxyl-terminal amino acid, valine, is amidated. Synthetic human secretin displays equivalent biological activity and properties as naturally-occurring secretin [A32265]. It is indicated for the stimulation of the pancreatic and gastric secretions to aid in the diagnosis of pancreatic exocrine dysfunction and the diagnosis of gastrinoma, and facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography (ERCP).
Indications and Usage Indicated for the stimulation of: - pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction [FDA Label]. - gastrin secretion to aid in the diagnosis of gastrinoma [FDA Label]. - pancreatic secretions to facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography (ERCP) [FDA Label].
Marketing Status approved
ATC Code V04CK01
DrugBank ID DB09532
KEGG ID D02021
MeSH ID D012633
PubChem ID 16129665
TTD Drug ID D0O8JB
NDC Product Code Not Available
UNII 88C55N56UU
Synonyms Secretin | Secretin Citrate, Pig | Pig Secretin Citrate | Secretin-KABI | Secretin KABI | SecretinKABI | Secretin Pentacetate, Pig | Pig Secretin Pentacetate | Secretin Sulfate, Pig | Pig Secretin Sulfate | Secretin, Pig | Pig Secretin | Secrepan | Secretin Maleate, Pig | Pig Secretin Maleate
Chemical Information
Molecular Formula C130H219N43O42
CAS Registry Number 1393-25-5
SMILES CC(C)CC(C(=O)NC(C(C)C)C(=O)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C )C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C (C)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N )N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(C C1=CC=CC=C1)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC2=NC=CN2)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal pain07.01.05.002--
Anxiety19.06.02.002--
Bradycardia02.03.02.002--Not Available
Cold sweat23.02.03.002; 08.01.03.024--Not Available
Diarrhoea07.02.01.001--
Dizziness24.06.02.007; 17.02.05.003; 02.11.04.006--
Dyspepsia07.01.02.001--
Feeling hot08.01.09.009--Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Gastrointestinal pain07.01.05.005--
Heart rate decreased13.14.04.001--Not Available
Heart rate increased13.14.04.002--Not Available
Hypotension24.06.03.002--
Injection site extravasation12.07.03.002; 08.02.03.002--Not Available
Loss of consciousness17.02.04.004--Not Available
Nausea07.01.07.001--
Oxygen saturation decreased13.02.01.004--Not Available
Pancreatitis07.18.01.001--
Paraesthesia23.03.03.094; 17.02.06.005--
Salivary hypersecretion07.06.01.009--Not Available
Sedation17.02.04.005--Not Available
Shock24.06.02.002--Not Available
Syncope02.11.04.015; 24.06.02.012; 17.02.04.008--
Tachycardia02.03.02.007--Not Available
Unresponsive to stimuli17.02.05.031--Not Available
Vomiting07.01.07.003--
Sticky skin23.03.03.019--Not Available
The 1th Page    1    Total 1 Pages